Literature DB >> 9731783

Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancer.

J B Rubins1, J Dunitz, H B Rubins, M A Maddaus, D E Niewoehner.   

Abstract

OBJECTIVE: To determine whether measurement of preoperative serum carcinoembryonic antigen concentrations adds useful prognostic data to current preoperative staging of lung cancer by computed tomography, bronchoscopy, and mediastinoscopy.
METHODS: A prospective cohort study of 130 consecutive patients was evaluated for suspected lung cancer from July 1991 through December 1992 at a university-affiliated Veterans Affairs Medical Center. Serum concentrations of carcinoembryonic antigen were measured before diagnosis, staging, or resection of cancer.
RESULTS: Malignant disease was diagnosed by bronchoscopy, needle biopsy, mediastinoscopy, or resection in 111 of 130 patients. In the 50 patients undergoing resection with curative intent, multivariate analysis indicated that carcinoembryonic antigen was a significant predictor of survival independent of patient age, pathologic stage, histologic type, and tumor size (P=.0357).
CONCLUSIONS: Elevated preoperative serum concentrations of carcinoembryonic antigen predict a poor prognosis for lung cancer independent of other conventional staging parameters and have an adjunctive role in the staging of lung cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9731783     DOI: 10.1016/S0022-5223(98)70007-8

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  11 in total

Review 1.  History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer.

Authors:  Haruhiko Nakamura; Toshihide Nishimura
Journal:  Surg Today       Date:  2017-02-22       Impact factor: 2.549

Review 2.  Prognostic and predictive biomarkers in early stage NSCLC: CTCs and serum/plasma markers.

Authors:  Philip A J Crosbie; Rajesh Shah; Yvonne Summers; Caroline Dive; Fiona Blackhall
Journal:  Transl Lung Cancer Res       Date:  2013-10

3.  Prognostic significance of the combined use of preoperative platelet count and serum carcinoembryonic antigen level in non-small-cell lung cancer.

Authors:  Masaki Tomita; Tetsuya Shimizu; Takanori Ayabe; Toshio Onitsuka
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-11-11

4.  Serum carcinoembryonic antigen level in non-small-cell lung cancer patients with preoperative normal serum level.

Authors:  Masaki Tomita; Tetsuya Shimizu; Masaki Hara; Takanori Ayabe; Toshio Onitsuka
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-06-17

5.  The prognostic value of carcinoembryonic antigen levels in blood and intraoperative pleural lavage fluid in non-small-cell lung cancer.

Authors:  Tevfik Ilker Akcam; Ufuk Cagirici; Ayse Gul Ergonul; Ali Ozdil; Onder Kavurmaci; Kutsal Turhan; Alpaslan Cakan; Burcu Barutcuoglu
Journal:  Kardiochir Torakochirurgia Pol       Date:  2017-06-30

6.  High Serum CEA and CYFRA21-1 Levels after a Two-Cycle Adjuvant Chemotherapy for NSCLC: Possible Poor Prognostic Factors.

Authors:  Xue-Feng Lin; Xiao-Dong Wang; Da-Qiang Sun; Zhi Li; Yue Bai
Journal:  Cancer Biol Med       Date:  2012-12       Impact factor: 4.248

7.  Pathologic correlation of serum carcinoembryonic antigen and cytokeratin 19 fragment in resected nonsmall cell lung cancer.

Authors:  Seokkee Lee; Chang Young Lee; Dae Joon Kim; Dae Jin Hong; Jin Gu Lee; Kyung Young Chung
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2013-06-05

8.  Prognostic value of serum leptin in advanced lung adenocarcinoma patients with cisplatin/pemetrexed chemotherapy.

Authors:  Wenjun Mou; Hui Xue; Hongli Tong; Shengjie Sun; Zhuhong Zhang; Chunyan Zhang; Qiyu Sun; Jing Dong; Xinyu Wen; Guangtao Yan; Yaping Tian
Journal:  Oncol Lett       Date:  2014-03-21       Impact factor: 2.967

9.  The Prognostic Value of Preoperative Serum Tumor Markers in Non-Small Cell Lung Cancer Varies With Radiological Features and Histological Types.

Authors:  Haiqing Chen; Fangqiu Fu; Yue Zhao; Haoxuan Wu; Hong Hu; Yihua Sun; Yawei Zhang; Jiaqing Xiang; Yang Zhang
Journal:  Front Oncol       Date:  2021-06-11       Impact factor: 6.244

10.  Serum dickkopf-1 as a clinical and prognostic factor in non-small cell lung cancer patients with bone metastases.

Authors:  Rong Qiao; Runbo Zhong; Qing Chang; Jiajun Teng; Jun Pei; Baohui Han; Tianqing Chu
Journal:  Oncotarget       Date:  2017-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.